LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile

When do Lidocaine Hydrochloride 0.4% And Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?

Lidocaine Hydrochloride 0.4% And Dextrose 5% In Plastic Container is a drug marketed by B Braun and Baxter Hlthcare and is included in three NDAs.

The generic ingredient in LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Lidocaine Hydrochloride 0.4% And Dextrose 5% In Plastic Container

A generic version of LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER was approved as lidocaine hydrochloride by WOCKHARDT BIO AG on November 18^th, 1982.

Summary for LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER

US Patents:	0
Applicants:	2
NDAs:	3
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	42
Clinical Trials:	1,820
DailyMed Link:	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed

Recent Clinical Trials for LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Sichuan Cancer Hospital and Research Institute	N/A
Jessyka Lighthall	Phase 3
Sawanpracharak hospital	N/A

See all LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER clinical trials

Pharmacology for LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER

Drug Class	Amide Local Anesthetic Antiarrhythmic
Physiological Effect	Local Anesthesia

US Patents and Regulatory Information for LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	lidocaine hydrochloride	INJECTABLE;INJECTION	018967-002	Mar 30, 1984		DISCN	No	No
B Braun	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	lidocaine hydrochloride	INJECTABLE;INJECTION	019830-003	Apr 8, 1992	AP	RX	No	No
Baxter Hlthcare	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	lidocaine hydrochloride	INJECTABLE;INJECTION	018461-003	Approved Prior to Jan 1, 1982	AP	RX	No	No

LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER Market Analysis and Financial Projection Experimental

Lidocaine Hydrochloride Market Dynamics and Financial Trajectory

Market Overview

The lidocaine hydrochloride market, particularly for formulations like Lidocaine Hydrochloride 0.4% and Dextrose 5% in plastic containers, is experiencing significant growth driven by several key factors.

Market Size and Growth

The global lidocaine hydrochloride market was valued at USD 0.89 billion in 2023 and is projected to grow to USD 1.49 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.26% during the forecast period (2024-2032)[1][3][5].

Key Drivers of Market Growth

Increasing Surgical Procedures

The growing number of surgical procedures, including dental, cosmetic, and plastic surgeries, is a major driver of the market. These procedures often require effective pain management solutions, for which lidocaine hydrochloride is a preferred choice[3][5].

Rising Prevalence of Chronic Pain

The increasing prevalence of chronic pain conditions worldwide is another significant factor. Lidocaine hydrochloride is widely used for managing acute and chronic pain, making it a crucial component in pain management strategies[1][5].

Aging Population

The expanding elderly population is a critical demographic driving the demand for lidocaine hydrochloride. Older individuals are more likely to undergo surgical procedures and experience chronic pain, thereby increasing the demand for effective pain management solutions[5].

Advances in Drug Delivery Technologies

Progress in drug delivery technologies has led to the development of innovative formulations such as creams, injections, and solutions like Lidocaine Hydrochloride 0.4% and Dextrose 5% in plastic containers. These advancements enhance the effectiveness and flexibility of lidocaine hydrochloride, contributing to market growth[5].

Distribution Channels

Hospital Pharmacies

Hospital pharmacies dominated the distribution channels segment in recent years and are expected to continue growing. Factors such as more client accessibility and lower operating costs contribute to the rise of hospital pharmacies[1].

Retail Pharmacies

Retail pharmacies are also a significant segment, driven by the increasing availability of over-the-counter (OTC) prescriptions and the high rate of generic penetration. The launch of OTC lidocaine hydrochloride products has further boosted the retail pharmacy sector[3][5].

Online Pharmacies

The COVID-19 pandemic has accelerated the use of online distribution channels for medications, including lidocaine hydrochloride. This trend is expected to continue, offering additional growth avenues for the market[1].

Regional Insights

Asia-Pacific

The Asia-Pacific region is anticipated to experience the fastest CAGR growth from 2022 to 2030. Countries like China and India are leading this growth due to an increase in dental and cosmetic surgeries, improvements in surgical techniques, and rising usage of lidocaine hydrochloride for postoperative pain treatment[1].

North America

North America dominated the global lidocaine hydrochloride market in 2023 and is expected to maintain its dominance. The region's growth is attributed to the rising number of aging people, an increase in surgical procedures, and advancements in pain management technologies[5].

Competitive Landscape

Major industry competitors are investing heavily in research and development to expand their product portfolios. Strategic efforts such as new product releases, contractual agreements, mergers and acquisitions, and collaborations are common among market participants. To remain competitive, companies must offer affordable options and address regulatory and safety concerns[1].

Regulatory Scrutiny and Safety Concerns

Regulatory scrutiny and potential side effects pose significant challenges to the market. Ensuring stringent adherence to safety standards and obtaining thorough approvals are critical. Additionally, competition from alternative pain management solutions and the need for continuous research to address safety concerns add complexity to market dynamics[5].

Financial Trajectory

Revenue Growth

The lidocaine hydrochloride market is expected to grow from USD 538.44 million in 2024 to USD 838.60 million by 2032, exhibiting a CAGR of 5.7% during the forecast period[5].

Spending Trends

The growth in the lidocaine hydrochloride market is also influenced by broader trends in drug expenditure. Protected brands, including new products, drive most of the growth, while generic share and biosimilars play significant roles in shaping the market dynamics[2].

Key Takeaways

• The lidocaine hydrochloride market is driven by increasing surgical procedures, rising chronic pain prevalence, and an aging population.
• Hospital and retail pharmacies are key distribution channels, with online pharmacies gaining traction.
• The Asia-Pacific region is expected to experience the fastest growth, while North America dominates the global market.
• Regulatory scrutiny and safety concerns are critical challenges that need to be addressed.
• The market is expected to grow significantly, driven by advancements in drug delivery technologies and increasing demand for pain management solutions.

FAQs

What are the primary drivers of the lidocaine hydrochloride market?

The primary drivers include the growing number of surgical procedures, increasing prevalence of chronic pain, and an expanding elderly population.

Which distribution channels are dominant in the lidocaine hydrochloride market?

Hospital pharmacies and retail pharmacies are the dominant distribution channels, with online pharmacies also gaining significance.

Which region is expected to experience the fastest growth in the lidocaine hydrochloride market?

The Asia-Pacific region is anticipated to experience the fastest CAGR growth from 2022 to 2030.

What are the challenges facing the lidocaine hydrochloride market?

Regulatory scrutiny, potential side effects, and competition from alternative pain management solutions are significant challenges.

What is the projected market size of the lidocaine hydrochloride market by 2032?

The market is expected to grow to USD 838.60 million by 2032.

Sources

1. Market Research Future: Lidocaine Market Analysis
2. IQVIA: Drug Expenditure Dynamics 1995-2020
3. Grand View Research: Lidocaine Hydrochloride Market Size & Share Report, 2030
4. DailyMed: Lidocaine Hydrochloride and 5% Dextrose Injection, USP
5. Polaris Market Research: Lidocaine Hydrochloride Market Size, Share, Global Analysis Report